VEXRX
Price
$94.76
Change
+$2.20 (+2.38%)
Updated
Apr 24 closing price
Net Assets
19.79B
WSMCX
Price
$13.55
Change
+$0.26 (+1.96%)
Updated
Apr 23 closing price
Net Assets
466.33M
Ad is loading...

VEXRX vs WSMCX

Header iconVEXRX vs WSMCX Comparison
Open Charts VEXRX vs WSMCXBanner chart's image
Vanguard Explorer Adm
Price$94.76
Change+$2.20 (+2.38%)
VolumeN/A
Net Assets19.79B
Allspring Small Company Growth C
Price$13.55
Change+$0.26 (+1.96%)
VolumeN/A
Net Assets466.33M
VEXRX vs WSMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VEXRX vs. WSMCX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEXRX is a Buy and WSMCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. WSMCX (466M). VEXRX pays higher dividends than WSMCX: VEXRX (0.56) vs WSMCX (0.00). VEXRX was incepted earlier than WSMCX: VEXRX (23 years) vs WSMCX (21 years). WSMCX (2.09) is less costly to investors than VEXRX (0.34). WSMCX is a more actively managed with annual turnover of: 40.00 vs. VEXRX (35.00). WSMCX has a lower initial minimum investment than VEXRX: WSMCX (1000) vs VEXRX (50000). VEXRX annual gain was more profitable for investors over the last year : -12.82 vs. WSMCX (-31.00). VEXRX return over 5 years is better than : 15.80 vs. WSMCX (-61.81).
VEXRXWSMCXVEXRX / WSMCX
Total Expense Ratio0.342.0317%
Annual Report Gross Expense Ratio0.342.0916%
Fund Existence23 years21 years-
Gain YTD-14.722-16.78188%
Front LoadN/AN/A-
Min. Initial Investment5000010005,000%
Min. Initial Investment IRAN/AN/A-
Net Assets19.8B466M4,249%
Annual Yield % from dividends0.560.00-
Returns for 1 year-12.82-31.0041%
Returns for 3 years-9.40-41.5623%
Returns for 5 years15.80-61.81-26%
Returns for 10 years-1.76-67.433%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI79.101.46
+1.88%
SPDR® S&P Biotech ETF
CHI9.780.17
+1.77%
Calamos Convertible Opportunities and Income Fund
SBIO28.020.45
+1.63%
ALPS Medical Breakthroughs ETF
BCDF28.540.12
+0.44%
Horizon Kinetics Blockchain Dev ETF
FEP41.67-0.06
-0.14%
First Trust Europe AlphaDEX® ETF